←Back to Expert Scholars
Translational Medicine / 转化医学T Cell Exhaustion, Functional Genomics
W. Nicholas Haining
BMBCh
🏢ArsenalBio (formerly Merck and Dana-Farber)🌐USA
Vice President, Discovery Oncology
75
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
W. Nicholas Haining used in vivo CRISPR screens to identify TOX and other regulators of T cell exhaustion. His work helped define progenitor versus terminal exhausted populations. He now leads cell therapy discovery aimed at preventing exhaustion in engineered T cells.
Share:
🧪Research Fields 研究领域
CRISPR screens
TOX biology
exhausted T cells
tumor immunology
cell engineering
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 W. Nicholas Haining 的研究动态
Follow W. Nicholas Haining's research updates
留下邮箱，当我们发布与 W. Nicholas Haining（ArsenalBio (formerly Merck and Dana-Farber)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment